Venmax Drugs & Pharmaceuticals Ltd

531015·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap19.60 Cr
PE Ratio80.50
Volume—
Day High - Low—
52W High-Low36.96 - 15.56

Venmax Drugs & Pharmaceuticals Ltd (531015): company summary

Venmax Drugs & Pharmaceuticals Ltd (531015) is a micro-cap Healthcare company valued at ₹20 crore operating in Pharmaceuticals on the NSE and BSE.

Venmax Drugs & Pharmaceuticals Ltd (531015) is a micro-cap Healthcare company valued at ₹20 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Profit grew 2.8% a year. Return on equity is 2.7%.
Valuation multiples
The stock trades at 80.5 times earnings, a premium to the Healthcare median of 32.5, 1.39 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
1.9/10
Poor
Fair Value
Sign in to see
ROE
2.70%
Weak
P/E
80.50x
Expensive
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

52W₹15.56
₹36.96
DocStoX take

Held back by valuation (0.0). Scored on 4 of 5 measures.

DocStoX score

Medium confidence
1.9
/10
Poor
Quality
Weak
ROE 2.7%
Valuation
Expensive
P/E 80.5×
Growth
Slow
Revenue +116.1% 5Y CAGR
Risk
Elevated
D/E 0.02
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹20 Cr
52W High / Low
₹37 / ₹16
Dividend Yield
0.00%
Promoter Holding
10.46%
EPS (TTM)
₹-0.02
Book Value
₹12.18

Key highlights

  • Revenue compounding 116% a year
  • Low leverage — D/E 0.02
  • Quality is weak (1.3/10)
  • Valuation is weak (0.0/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Venmax Drugs & Pharmaceuticals Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Venmax Drugs & Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED

Compare Venmax Drugs & Pharmaceuticals Ltd with peers

Venmax Drugs & Pharmaceuticals Ltd vs SUN PHARMACEUTICAL IND LVenmax Drugs & Pharmaceuticals Ltd vs DIVI S LABORATORIES LTDVenmax Drugs & Pharmaceuticals Ltd vs TORRENT PHARMACEUTICALS LVenmax Drugs & Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. LVenmax Drugs & Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTDVenmax Drugs & Pharmaceuticals Ltd vs CIPLA LTD

Related tools & concepts

Value Venmax Drugs & Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing